HHS STATEMENT
U.S. Department of Health and Human Services
STATEMENT Print Media: 301-827-6242
February 9, 2000
Consumer Inquiries: 888-INFO-FDA
FDA STATEMENT CONCERNING STRUCTURE/FUNCTION RULE*
AND PREGNANCY CLAIMS
To ensure that careful consideration is given to concerns recently raised
regarding how the structure/function rule relates to pregnancy, FDA today is
advising dietary supplement manufacturers not to make any claims related to
pregnancy on their products based on the agency's recently issued
structure/function rule. FDA will issue a Federal Register notice shortly
describing these concerns in more detail, stating the agency's intention to
fully review these concerns, hold a public meeting related to potential
pregnancy related safety concerns, and then issue further guidance. FDA urges
all pregnant women to consult their health care provider before taking any
dietary supplements or medication.
####
*Citation: 65 FR 1000; January 6, 2000; Docket No. 98N-0044
This is a mirror of the page at
HTTP://www.fda.gov/bbs/topics/NEWS/NEW00715.html
More
Information for the Public Meeting (agenda, questions to be
addressed, dockets)
Federal Register Notice of April 24, 2000
meeting (February 24, 2000)
This document was issued on February 9, 2000.
For more recent information on Dietary Supplements
See
http://www.cfsan.fda.gov/~dms/supplmnt.html
Dietary Supplements
Foods Home
|
FDA Home
|
Search/Subject Index
|
Disclaimers & Privacy Policy